- Cosmos Health increases its Ethereum investment to $1.8 million under a $300 million digital asset plan.
- CEO Greg Siokas says the company remains committed to accelerating cryptocurrency acquisitions.
- Shares rise 200% in six months as Cosmos expands into healthcare and digital finance.
Cosmos Health Inc. (NASDAQ: COSM) has strengthened its digital asset holdings with a recent purchase of Ethereum (ETH) worth $300,000, bringing the healthcare group’s total investment in the cryptocurrency to $1.8 million.
The move, announced Monday, is part of the company’s broader $300 million digital asset program designed to diversify the portfolio and support long-term growth.
Headquartered in Chicago and active in manufacturing, distribution and telepharmacy services, Cosmos Health has become increasingly engaged in the digital asset space over recent months.
The company’s shares have climbed nearly 200% over the past six months.
Strategic expansion through digital assets
Cosmos Health’s latest Ethereum acquisition underscores its commitment to integrating digital assets into a wider financial strategy.
“We have continued to increase our Ethereum holdings following last week’s purchase, bringing our total investment in ETH to $1.8 million,” said CEO Greg Siokas.
“We remain committed to accelerating our acquisition program under our $300 million financing facility,” he added, emphasizing the company’s intent to broaden its exposure to blockchain-based assets.
The purchase follows a series of prior cryptocurrency investments made under the same program, which the company first announced earlier this year.
The initiative reflects Cosmos Health’s diversification approach, balancing its core healthcare operations with emerging opportunities in finance and digital technology.
Founded in 2009 and incorporated in Nevada, Cosmos Health operates across several key healthcare segments, including nutraceuticals, branded pharmaceuticals and healthcare distribution.
The company’s operations span Greece and the United Kingdom, with major distribution hubs located in Thessaloniki, Athens and Harlow.
Broader strategic developments
Beyond digital assets, Cosmos Health has actively pursued corporate and operational initiatives to expand its global footprint.
The company recently announced the appointment of Theodoros C. Karkantzos to its board of directors.
Karkantzos brings more than 15 years of investment and business development experience and will serve on the Nominations and Corporate Governance Committee.
Additionally, Cosmos Health expanded its Sky Premium Life brand into Kuwait through an exclusive distribution agreement with Diyar United.
Under the agreement, Diyar United will market and distribute the company’s nutraceutical products across the Kuwaiti market, further strengthening Cosmos Health’s international presence.
At its most recent annual shareholder meeting, the company also received approval to increase its authorized shares to 1.5 billion common shares and 300 million preferred shares, a step intended to provide greater financial flexibility.
A diversified path forward
Cosmos Health’s growing commitment to digital assets, particularly Ethereum, reflects a broader trend of traditional companies exploring blockchain integration and cryptocurrency investments as part of their diversification strategies.
While the company’s primary focus remains healthcare and wellness, its move into digital assets and strategic partnerships signals a forward-looking approach to technology-driven financial management.
With total Ethereum holdings now at $1.8 million and a $300 million facility available for further expansion, Cosmos Health appears positioned to continue balancing innovation across financial and healthcare markets while pursuing sustainable long-term growth.